Open access
Aug 2026
Long-term effects of denosumab: a 10-year single-center retrospective study
Osteoporosis weakens bones and increases the risk of fractures. Denosumab is a medication that reduces bone loss and increases bone mineral density (BMD). In this real-world study, we followed patients who received denosumab every 6 months for 10 years. We found that bone density continued to improve throughout treatme...
F. Aldegheri, Matteo Appoloni, Nicolò Passoni et al.
· Archives of Osteoporosis · 0 citations